These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21709617)

  • 1. Design issues in head and neck clinical trials: a statistician's perspective.
    Fortpied C; Liberatoscioli C; Bogaerts J
    Anticancer Drugs; 2011 Aug; 22(7):682-7. PubMed ID: 21709617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial design limitations in head and neck squamous cell carcinomas.
    Yun HJ; Bogaerts J; Awada A; Lacombe D
    Curr Opin Oncol; 2007 May; 19(3):210-5. PubMed ID: 17414638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pragmatic problems with clinical equipoise.
    Kowalski CJ
    Perspect Biol Med; 2010; 53(2):161-73. PubMed ID: 20495255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group-sequential methods for adaptive seamless phase II/III clinical trials.
    Stallard N
    J Biopharm Stat; 2011 Jul; 21(4):787-801. PubMed ID: 21516569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG.
    Au HJ; Ringash J; Brundage M; Palmer M; Richardson H; Meyer RM;
    Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):119-28. PubMed ID: 20384559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial design in head and neck cancer: what has the oncologist learned?
    Adelstein DJ
    Lancet Oncol; 2012 Jul; 13(7):e318-23. PubMed ID: 22748271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to clinical trial recruitment in head and neck cancer.
    Haddad RI; Chan AT; Vermorken JB
    Oral Oncol; 2015 Mar; 51(3):203-11. PubMed ID: 25593017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012.
    Preusser M; Winkler F; Collette L; Haller S; Marreaud S; Soffietti R; Klein M; Reijneveld JC; Tonn JC; Baumert BG; Mulvenna P; Schadendorf D; Duchnowska R; Berghoff AS; Lin N; Cameron DA; Belkacemi Y; Jassem J; Weber DC
    Eur J Cancer; 2012 Dec; 48(18):3439-47. PubMed ID: 22883982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Design and endpoints of clinical trials in hepatocellular carcinoma.
    Di Maio M; Daniele B; Gallo C; Perrone F
    J Natl Cancer Inst; 2008 Nov; 100(21):1557; author reply 1557-8. PubMed ID: 18957679
    [No Abstract]   [Full Text] [Related]  

  • 11. Interim futility analysis with intermediate endpoints.
    Goldman B; LeBlanc M; Crowley J
    Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of statistical significance.
    Kane RC
    Oncologist; 2008 Nov; 13(11):1129-33. PubMed ID: 18984874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of sensitivity analyses in assessing progression-free survival in late-stage oncology trials.
    Bhattacharya S; Fyfe G; Gray RJ; Sargent DJ
    J Clin Oncol; 2009 Dec; 27(35):5958-64. PubMed ID: 19826121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A statistician's perspective on a long time to publish.
    Dueck AC
    Lancet Haematol; 2017 Jan; 4(1):e12. PubMed ID: 27916632
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial design issues in the era of targeted therapies.
    Schiller JH
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4281s-4282s. PubMed ID: 15217975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 25-year review of sequential methodology in clinical studies.
    Todd S
    Stat Med; 2007 Jan; 26(2):237-52. PubMed ID: 17139691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalizing cancer care: updates on head and neck cancer.
    de Souza JA; Cohen EE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The training of statisticians for cooperative clinical trials: a working statistician's viewpoint.
    Gehan EA
    Biometrics; 1980 Dec; 36(4):699-706. PubMed ID: 7248438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential designs for phase III clinical trials incorporating treatment selection.
    Stallard N; Todd S
    Stat Med; 2003 Mar; 22(5):689-703. PubMed ID: 12587100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.